Literature DB >> 17307165

Hematopoietic growth factors pass through the blood-brain barrier in intact rats.

Li-Ru Zhao1, Yot Navalitloha, Seema Singhal, Jayesh Mehta, Chun-Shu Piao, Wen-Ping Guo, John A Kessler, Dennis R Groothuis.   

Abstract

We have previously demonstrated that receptors for hematopoietic growth factors, stem cell factor (SCF) and granulocyte-colony stimulating factor (G-CSF) are expressed in the neurons and the neural progenitor cells (NPCs) of the adult rat brain, and that systemic administration of SCF and G-CSF in the first week after induction of cortical brain ischemia (3 h-7 days post-ischemia) significantly improves functional outcome, augments NPC proliferation, and reduces infarct volume in rats. The purpose of the present study is to determine whether SCF and G-CSF pass through the blood-brain barrier (BBB) in intact rats. The growth factors were labeled with iodine (I(125)), a radioactive compound. I(125)-SCF and I(125)-G-CSF were intravenously administered and the concentrations of I(125)-SCF and I(125)-G-CSF in the blood plasma and the brain were determined at 10, 30, 60, and 120 min after injection. We observed that both SCF and G-CSF were slowly and continuously transported from the blood stream to the brain in the same rate. In addition, both immunofluorescent staining and Western blots showed that receptors for SCF and G-CSF were expressed in the capillaries of the adult rat brain, suggesting that SCF and G-CSF entry to the brain may be mediated via receptor-mediated transport, one of the endogenous transports in the BBB. These data indicate that both SCF and G-CSF were able to pass through the BBB in intact animals. This observation will help in further exploring the physiological role of peripheral SCF and G-CSF in the brain and therapeutic possibility to chronic stroke.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17307165      PMCID: PMC3099460          DOI: 10.1016/j.expneurol.2006.12.001

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  25 in total

1.  The structure of granulocyte-colony-stimulating factor and its relationship to other growth factors.

Authors:  C P Hill; T D Osslund; D Eisenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-01       Impact factor: 11.205

Review 2.  Filgrastim (r-metHuG-CSF): the first 10 years.

Authors:  K Welte; J Gabrilove; M H Bronchud; E Platzer; G Morstyn
Journal:  Blood       Date:  1996-09-15       Impact factor: 22.113

3.  Relationship of octanol/water partition coefficient and molecular weight to rat brain capillary permeability.

Authors:  V A Levin
Journal:  J Med Chem       Date:  1980-06       Impact factor: 7.446

Review 4.  Biology and clinical potential of stem-cell factor.

Authors:  J Glaspy; M W Davis; W R Parker; M Foote; I McNiece
Journal:  Cancer Chemother Pharmacol       Date:  1996       Impact factor: 3.333

5.  Stem cell factor in combination with filgrastim after chemotherapy improves peripheral blood progenitor cell yield and reduces apheresis requirements in multiple myeloma patients: a randomized, controlled trial.

Authors:  T Facon; J L Harousseau; F Maloisel; M Attal; J Odriozola; A Alegre; W Schroyens; C Hulin; R Schots; P Marin; F Guilhot; A Granena; M De Waele; A Pigneux; V Méresse; P Clark; J Reiffers
Journal:  Blood       Date:  1999-08-15       Impact factor: 22.113

6.  Steel mutant mice are deficient in hippocampal learning but not long-term potentiation.

Authors:  B Motro; J M Wojtowicz; A Bernstein; D van der Kooy
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-05       Impact factor: 11.205

7.  Functional recovery of stroke rats induced by granulocyte colony-stimulating factor-stimulated stem cells.

Authors:  Woei-Cherng Shyu; Shinn-Zong Lin; Hui-I Yang; Yi-Shiuan Tzeng; Cheng-Yoong Pang; Pao-Sheng Yen; Hung Li
Journal:  Circulation       Date:  2004-09-20       Impact factor: 29.690

Review 8.  The kit ligand, stem cell factor.

Authors:  S J Galli; K M Zsebo; E N Geissler
Journal:  Adv Immunol       Date:  1994       Impact factor: 3.543

Review 9.  Anti-inflammatory effects of granulocyte colony-stimulating factor.

Authors:  T Hartung
Journal:  Curr Opin Hematol       Date:  1998-05       Impact factor: 3.284

Review 10.  A comparative review of colony-stimulating factors.

Authors:  J Nemunaitis
Journal:  Drugs       Date:  1997-11       Impact factor: 11.431

View more
  49 in total

1.  pH responsive granulocyte colony-stimulating factor variants with implications for treating Alzheimer's disease and other central nervous system disorders.

Authors:  Pete Heinzelman; Jennifer A Schoborg; Michael C Jewett
Journal:  Protein Eng Des Sel       Date:  2015-04-15       Impact factor: 1.650

Review 2.  Blood-brain barrier integrity and glial support: mechanisms that can be targeted for novel therapeutic approaches in stroke.

Authors:  Patrick T Ronaldson; Thomas P Davis
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

3.  Stem Cell Factor (SCF) is a putative biomarker of antidepressant response.

Authors:  Francesco Benedetti; Sara Poletti; Thomas A Hoogenboezem; Clara Locatelli; Oliver Ambrée; Harm de Wit; Annemarie J M Wijkhuijs; Elena Mazza; Chiara Bulgarelli; Benedetta Vai; Cristina Colombo; Enrico Smeraldi; Volker Arolt; Hemmo A Drexhage
Journal:  J Neuroimmune Pharmacol       Date:  2016-04-23       Impact factor: 4.147

4.  Neuroprotective effects of G-CSF administration in microglia-mediated reactive T cell activation in vitro.

Authors:  Wei Peng
Journal:  Immunol Res       Date:  2017-08       Impact factor: 2.829

Review 5.  Blood-brain barrier dysfunction in ischemic stroke: targeting tight junctions and transporters for vascular protection.

Authors:  Wazir Abdullahi; Dinesh Tripathi; Patrick T Ronaldson
Journal:  Am J Physiol Cell Physiol       Date:  2018-06-27       Impact factor: 4.249

Review 6.  Control of brain development, function, and behavior by the microbiome.

Authors:  Timothy R Sampson; Sarkis K Mazmanian
Journal:  Cell Host Microbe       Date:  2015-05-13       Impact factor: 21.023

7.  Granulocyte Macrophage Colony Stimulating Factor Treatment is Associated with Improved Cognition in Cancer Patients.

Authors:  Heather Sl Jim; Tim D Boyd; Margaret Booth-Jones; Joseph Pidala; Huntington Potter
Journal:  Brain Disord Ther       Date:  2012

8.  Neurotrophic growth factors for the treatment of amyotrophic lateral sclerosis: where do we stand?

Authors:  Alexandre Henriques; Claudia Pitzer; Armin Schneider
Journal:  Front Neurosci       Date:  2010-06-11       Impact factor: 4.677

9.  Turning Death to Growth: Hematopoietic Growth Factors Promote Neurite Outgrowth through MEK/ERK/p53 Pathway.

Authors:  Mei Gao; Li-Ru Zhao
Journal:  Mol Neurobiol       Date:  2017-11-08       Impact factor: 5.590

10.  Granulocyte-colony stimulating factor improves outcome in a mouse model of amyotrophic lateral sclerosis.

Authors:  Claudia Pitzer; Carola Krüger; Christian Plaas; Friederike Kirsch; Tanjew Dittgen; Ralph Müller; Rico Laage; Stefan Kastner; Stefanie Suess; Robert Spoelgen; Alexandre Henriques; Hannelore Ehrenreich; Wolf-Rüdiger Schäbitz; Alfred Bach; Armin Schneider
Journal:  Brain       Date:  2008-10-03       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.